Stryker Corporation (SYK) - FREE Research Report

Stryker Ronda E who is Director at Stryker Corporation sold 14,000 shares at $67.74 on Oct. 8, 2013. Following this transaction, the Director owned 11.7 million shares meaning that the stake was reduced by 0.12% with the 14,000 share transaction.

The shares most recently traded at $67.54, down $0.20, or 0.29% since the insider transaction. Historical insider transactions for Stryker Corporation go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 28,000

The average volume for Stryker Corporation has been 1.2 million shares per day over the past 30 days. Stryker Corporation has a market cap of $26.8 billion and is part of the health care sector and health services industry. Shares are up 29.2% year to date as of the close of trading on Friday.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. The stock currently has a dividend yield of 1.5%. The company has a P/E ratio of 23.8. Currently there are 13 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYK - FREE

TheStreet Quant Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

7 Bargain-Basement Stocks That Could Rebound in 2017

This Year's Jewels in Last Year's Junk

Gun Stocks Are a Risky Play in 2017 -- Here's Why

Jim Cramer's 'Mad Money' Recap: Don't Worry About a Little Market Detour

'Mad Money' Lightning Round: Wynn Resorts vs. MGM, Ford vs. General Motors